SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
11376182
Source:
http://linkedlifedata.com/resource/pubmed/id/11376182
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0026769
,
umls-concept:C0035020
,
umls-concept:C0205199
,
umls-concept:C0205245
,
umls-concept:C0231170
,
umls-concept:C0681842
,
umls-concept:C1524063
,
umls-concept:C2349943
pubmed:issue
10
pubmed:dateCreated
2001-5-28
pubmed:abstractText
To determine whether the MS Functional Composite (MSFC) can predict future disease progression in patients with relapsing remitting MS (RR-MS).
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/P01 NS38667
,
http://linkedlifedata.com/resource/pubmed/grant/R01 26321
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta 1a
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0028-3878
pubmed:author
pubmed-author:BaierMM
,
pubmed-author:CutterGG
,
pubmed-author:DoughertyDD
,
pubmed-author:FisherEE
,
pubmed-author:LemaW JWJ
,
pubmed-author:MillerDD
,
pubmed-author:RudickR ARA
,
pubmed-author:SimonianN ANA
,
pubmed-author:Weinstock-GuttmanBB
pubmed:issnType
Print
pubmed:day
22
pubmed:volume
56
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1324-30
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11376182-Adult
,
pubmed-meshheading:11376182-Atrophy
,
pubmed-meshheading:11376182-Brain
,
pubmed-meshheading:11376182-Clinical Trials, Phase III as Topic
,
pubmed-meshheading:11376182-Disability Evaluation
,
pubmed-meshheading:11376182-Female
,
pubmed-meshheading:11376182-Health Status
,
pubmed-meshheading:11376182-Humans
,
pubmed-meshheading:11376182-Interferon-beta
,
pubmed-meshheading:11376182-Magnetic Resonance Imaging
,
pubmed-meshheading:11376182-Male
,
pubmed-meshheading:11376182-Multiple Sclerosis, Relapsing-Remitting
,
pubmed-meshheading:11376182-Predictive Value of Tests
,
pubmed-meshheading:11376182-Prognosis
,
pubmed-meshheading:11376182-Questionnaires
,
pubmed-meshheading:11376182-Reproducibility of Results
,
pubmed-meshheading:11376182-Treatment Outcome
pubmed:year
2001
pubmed:articleTitle
Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS.
pubmed:affiliation
Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, OH 44195, USA. rudick@ccf.org
pubmed:publicationType
Journal Article
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't